|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.3 TWD | +2.20% |
|
+10.24% | +19.88% |
| Mar. 11 | TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024 | CI |
| Mar. 11 | TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024 | CI |
TSH Biopharm Corporation Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 117.46 million compared to TWD 120.45 million a year ago. Net income was TWD 10.68 million compared to TWD 19.42 million a year ago.
Basic earnings per share from continuing operations was TWD 0.28 compared to TWD 0.51 a year ago. Diluted earnings per share from continuing operations was TWD 0.28 compared to TWD 0.51 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +19.88% | 70.98M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
TSH BIOPHARM CORPORATION LIMITED 
